[1] KHADER Y S, BATIEHA A, AL-NJADAT R A, et al. Preeclampsia in Jordan: incidence, risk factors, and its associated maternal and neonatal outcomes[J].J Matern Fetal Neonatal Med,2018,31(6):770-776.
[2] LI L, ZHENG Y, ZHU Y, et al. Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia[J].Exp Ther Med,2016,12(4):2515-2520.
[3] SINGNOI W, WANAPIRAK C, SEKARARITHI R, et al. A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study[J].BMC Pregnancy Childbirth,2019,19(1):124.
[4] ABDI F, AGHAIE Z, RAHNEMAIE F S, et al. A systematic review of first trimester biochemical and molecular predictive tests for preeclampsia[J].Curr Hypertens Rev,2018,14(1):21-28.
[5] 杨孜.妊娠期急性高血压治疗指南(2015年)[C].//2015第五届两江母胎医学论坛论文集.北京大学第三医院,2015:109-115.
[6] BROUMAND F, LAK S S, NEMATI F, et al. A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women[J].Electron Physician,2018,10(1):6186-6192.
[7] SALVIG J D. Pre-eclampsia - a pregnancy complication with many facets [J].Ugeskr Laeger,2017,179(14): V68968.
[8] 廖媛,张静,陈锰, 等.重度子痫前期单双胎妊娠不良结局的高危因素分析[J].实用妇产科杂志,2015,31(10):771-775.
[9] 李丽洁,王梁萍,郑艳鹛.抑制素A、激活素A与子宫动脉搏动指数联合预测子痫前期的效果分析[J].预防医学,2017,29(3):251-254.
[10] 胡燕,张玲,吴盼星, 等.正常孕妇不同孕周血清抑制素A的浓度及其与子痫前期发病的相关性研究[J].中国现代医生,2017,55(14):57-60.
[11] 陈清梅,陆丽,李岩, 等.尿抑制素A、尿α1-微球蛋白表达水平对子痫前期预测价值分析[J].中国计划生育学杂志,2018,26(8):737-740.
[12] 卢健翔,石瑾秋,周明, 等.抑制素A与子痫前期及子痫的相关性研究[J].医学临床研究,2016,33(10):1985-1989.
[13] 尹迎辉,许红梅,吴宝萍, 等.中孕期血清抑制素预测子痫前期发病的Meta分析[J].现代妇产科进展,2013,22(9):746-747.
[14] SVIRSKY R, MAYMON R, MELCER Y, et al. First and second trimester maternal serum inhibin A levels in twins with pre-eclampsia[J].Prenat Diagn,2016,36(11):1071-1074.
[15] 果崇慧,杨青,赵雪莲, 等.子痫前期相关危险因素的临床分析[J].河北医药,2016,38(16):2465-2467.
2021, Vol. 38 
